2023-04-25 02:55:08 ET
- Nanobiotix press release ( NASDAQ: NBTX ): FY GAAP EPS of -€1.64.
-
As of December 31, 2022, Nanobiotix had €41.4 million in cash and cash equivalents, compared to €83.9 million as of December 31, 2021.
-
Based on the current operating plan and financial projections, Nanobiotix anticipates that the cash and cash equivalents of €41.4 million as of December 31, 2022, in conjunction with its previously announced equity line financing will fund its operations into the third quarter of 2023.
For further details see:
Nanobiotix GAAP EPS of -€1.64